Hospital use of sugammadex, methoxyflurane, COX-2 inhibitors and gabapentin

Hospital devices Decision

PHARMAC is pleased to announce the approval of proposals relating to the hospital use of sugammadex, methoxyflurane, COX-2 inhibitors and gabapentin.

These proposals were the subject of two consultation letters dated 18 April 2013 (sugammadex consultation and methoxyflurane, COX-2 inhibitors and gabapentin consultation [link no longer avalable]).

Notification of decisions on hospital use of sugammadex, methoxyflurane, COX-2 inhibitors and gabapentin